Skills Group for Youth at Clinical High-Risk for Psychosis

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT05398120
Status
Recruiting
Apply to this trial

Conditions

  • Clinical High-Risk
  • Psychological

Eligibility Criteria

Sex
ALL
Age
13 Years - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • Skills Group — BEHAVIORAL
    Adolescents and young adults with a CHR syndrome ages 13-18 will complete feasibility and outcome measures while participating in a weekly skills group for 6 months.

Study Details

This study is intended to test the feasibility of an integrated cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) skills group for adolescents and young adults at clinical high-risk (CHR) for psychosis. The current study applies a skills group drawing from evidence-based practices (e.g., cognitive behavioral therapy (CBT), dialectical behavioral therapy (DBT)) to those at CHR for psychosis. Up to 30 CHR individuals (starting with a minimum of 3 participants, N accounts for attrition as well), aged 13-18, already receiving clinical services within the HOPE team at University of Pittsburgh will be offered a weekly skills group. Data collected on feasibility and outcome measures will occur pre (within 1 month) -post (up to 4-5 months) and half-way (up to 2-3 months) through the intervention. Taken together, the aim of the proposed intervention is to provide novel insights regarding the utility of a newly developed intervention that integrates both CBT and DBT skills for those at CHR for psychosis.

Key Dates

Start date
Apr 26, 2022
Status verified
Feb 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Skills Group
    There will be one condition which is the group and participants will complete feasibility and outcome measures at baseline, at midpoint, and at the end of the group.

Primary Outcome Measure

Attrition [ Time Frame: Up to 5 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Bellefield TowersPittsburghPennsylvania15213
Tina Gupta, MA
[email protected]
412-246-5845
Leslie Horton, PHD
Leslie Horton, PHD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

By research site
Bellefield Towers· Pittsburgh, PA

Related Studies